Type 2 Diabetes Trial, Recruiting NCT06180837 Sponsor: University of Utah Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06180837
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 45 years old (the trial aims to include equal numbers of men and women)
  • People with a body mass index (BMI) between 27.5 and 34.9 (this is a measure of body weight relative to height — the trial site can confirm whether a person's BMI falls in this range)
  • People who have been regularly sleeping less than 6.5 hours per night on average for the past 6 months, based on their own reporting

Who may not be able to join:

  • People who have been diagnosed with a sleep disorder or a major mental health condition
  • People with significant problems affecting major organs, such as heart disease or kidney disease
  • People who have been diagnosed with diabetes, or whose blood sugar test results are above certain levels
  • People who are currently taking prescription medications or other substances known to affect sleep or blood sugar, or who take blood-thinning medications
  • People whose cancer has been in remission for less than 5 years
  • People who are pregnant, breastfeeding, going through menopause, or post-menopausal
  • People who currently work shift work, or have done so within the past year
  • People whose body weight has changed by more than 10% in the past six months
  • People currently enrolled in a weight loss or physical activity program (such as the Diabetes Prevention Program)
  • People who currently smoke
  • People who drink more than 14 alcoholic drinks per week, or more than 3 drinks on any single day

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 801-581-2275

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 February 2024
Est. completion
1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Total Plasma Ceramides; Insulin Sensitivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov